Spravato's ketamin price 2025?

Spravato (intranasal esketamine) pricing in 2025 depends heavily on country, insurance coverage, and whether you’re paying cash vs. using a co-pay program. I don’t have live 2025 pricing feeds here, but I can tell you the typical way pricing is determined and help you estimate what you might pay.

Quick context (what drives cost)

• Dose/session: Spravato is usually billed per treatment session (commonly 56 mg or 84 mg depending on the indication/titration).
• Setting: Given only in a certified clinic under monitoring—so the “total cost” may include clinic/administration charges.
• Insurance: Many patients pay only a co-pay after insurance, while uninsured patients may face much higher cash prices.
• Eligibility programs: Some manufacturers/patient assistance/co-pay cards can reduce out-of-pocket costs.

To give you an accurate 2025 number

Tell me these 3 things:

1. What country/state are you in? (U.S.? Canada? UK? etc.)
2. Are you insured or paying cash?
3. Which dose strength (56 mg or 84 mg) and roughly how often (weekly, etc.)?

If you’re in the U.S.

The U.S. list price and patient out-of-pocket can differ a lot. If you confirm:

• your state (or just “U.S.”),
• insured vs uninsured, and
• dose,
  I can estimate your likely per-session and monthly range and point you to the right places to check the most current 2025 numbers (e.g., insurer-specific pricing, co-pay program limits, typical reimbursement patterns).

Reply with your country + insured/cash + dose and I’ll narrow it down.